Director, Social Impact & Sustainability Strategy

Salary Range

CHF - CHF

We’re a team of dedicated and smart people united by a drive to achieve together. You will ensure Novartis Social Impact & Sustainability (SI&S) Strategy will remain fit for purpose and up to date, in line with Novartis corporate strategy priorities, external developments, stakeholder expectations and evolving regulatory landscape. You will independently develop, lead, and implement key strategic priorities – with a ~50% focus on Environmental Sustainability and ~50% focus on Social Impact topics.

This role reports into the Global Head, Social Impact & Sustainability Strategy, Integration & Measurement and works closely with the Head of Social Impact and Chief Sustainability Officer, the ESG Committee (Novartis Executive-level decision Board for Social Impact & Sustainability), and Executive-1 and
-2 leaders.

• Drive the evolution of Novartis’ SI&S strategy and roadmap - including Environmental Sustainability (incl. carbon, water, waste/circularity, and nature/biodiversity), Social Impact (Health Equity/Inclusive Access, Philanthropy) & other ESG topics.
• Ensure Novartis SI&S targets and priorities are fit for purpose, and aligned with latest external expectations, standards and frameworks.
• Identify opportunities to accelerate progress on Novartis’ ambitious SI&S targets; drive continuous improvement by providing expert guidance across different business functions (incl. Operations, Development, Commercial).
• Support the Global Head SI&S Strategy, Business Integration & Measurement in defining and driving key initiatives; support strategic “bold moves” in Environmental Sustainability & ESG for Novartis Group, the CEO, the Novartis ESG Committee (Executive-level decision body) and Board of Directors.
• Independently drive and lead high profile, company-wide strategic initiatives with a focus on (1) new strategic priorities, for embedding into the business (e.g., new opportunities in Climate Change & Health, new initiatives to accelerate inclusive access to medicines); (2) acceleration of key existing priorities (e.g., further refining Carbon Transition Plan and requirements to achieve 2030 and 2024 environmental targets); (3) cross-functional initiatives and projects, translating and scaling strategy into enterprise/business unit/function/country programmes.
• Ideate, develop and implement “big bold moves” concepts for SI&S; ensuring Novartis SI&S agenda stays competitive and differentiated vs. peers; partner with public and private stakeholders to drive meaningful impact.
• Support colleagues in business units and functions as advisor and sparring partner, ensuring consistent implementation of global strategy across the business (e.g., teams in Global Health, Patient Access, Ethics & Compliance, Finance & Reporting, Investor Relations).
• Be on the forefront of knowledge in the sustainability and ESG space in the industry; keep abreast of evolving regulations, standards and industry trends; translate external developments into strategic implications and options.
• Participate in industry groups, represent Novartis in external discussions, and shape standards for our industry (e.g., Pharmaceutical Environment Group, WBCSD, Sustainable Markets Initiative).

• Degree in Business, Strategy, Engineering, Sustainability or Life Sciences (MBA a plus); or equivalent on-the-job experience.
• While acting as an “ESG strategy generalist”, strong expert knowledge of Environmental Sustainability topics and practices (carbon, water, waste/circularity, nature/biodiversity), including key trends, standards and frameworks (incl. science-based targets).
• Proven track record of concrete achievements in ESG, Social Impact & Environmental Sustainability projects and strategy work, driving and influencing corporates’ SI&S agenda.
• Extensive project and program management experience in strategic projects; ability to develop and manage projects with high quality, interact with senior management and lead cross-functional project teams (internal stakeholders and external providers).
• Ability to balance strategic intent with operational reality;…